Pancreatic cancer has been unresponsive to both anti-programmed death 1 (anti-PD-1) and anti-cytotoxic T-lymphocyte-associated antigen 4 (anti-CTLA-4) [11, 12]. The gene discussed is CTLA4; the disease is familial pancreatic carcinoma.